Methods and compositions for treating neuropathic and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01)

Patent

CA 2561714

Disclosed herein are engineered zinc finger proteins which modulate transcription of the gene encoding vascular endothelial growth factor-A (VEGF- A) and other genes encoding products with neurotrophic activities. Also disclosed are methods for the use of these engineered zinc finger proteins in the treatment of neuropathy (including diabetic neuropathy), and other types of neural injury and neurodegeneration.

L'invention concerne des protéines à doigts de zinc recombinées qui modulent la transcription du gène codant pour le facteur de croissance endothéliale A (VEGF-A) et d'autres produits géniques codants présentant des activités neurotrophiques. L'invention concerne également des méthodes d'utilisation de ces protéines à doigts de zinc pour le traitement des neuropathies (y compris de la neuropathie diabétique), et d'autres types de lésions nerveuses et de neurodégénérations.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for treating neuropathic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treating neuropathic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating neuropathic and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1917501

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.